Both lisinopril and spironolactone raise potassium levels, and combining them significantly increases the risk of life-threatening hyperkalemia. This can cause cardiac arrhythmias and cardiac arrest. While this combination is sometimes used intentionally in heart failure management, it requires careful monitoring.
How This Interaction Works (Mechanism)
Lisinopril reduces aldosterone production by inhibiting the renin-angiotensin-aldosterone system, which decreases potassium excretion by the kidneys. Spironolactone directly blocks aldosterone receptors in the collecting duct, further reducing potassium excretion. Together, they create a powerful potassium-sparing effect that can push serum potassium above 6.0 mEq/L, causing dangerous cardiac conduction abnormalities including peaked T waves, widened QRS complexes, and ventricular fibrillation.
Source: American College of Cardiology Heart Failure Guidelines, 2025
This combination should only be used under close medical supervision with frequent potassium and kidney function monitoring (at least every 1 to 2 weeks initially, then monthly). Avoid potassium supplements and salt substitutes containing potassium. Stay well hydrated. Report muscle weakness, numbness, palpitations, or irregular heartbeat immediately. Your doctor will use the lowest effective doses of both medications.
Check More Drug Interactions
Use our free interaction checker to search thousands of drug, supplement, and food combinations.
Open Interaction CheckerTrack it between visits
As an Amazon Associate I earn from qualifying purchases.
Sources and standards behind this page
What a drug interaction does, and how strongly it is supported, is documented in public labeling and federal safety references rather than in any one summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- DailyMed carries the current FDA labeling for every marketed drug product, including the warnings and drug interaction sections.
- Drugs@FDA is the federal database of approved drug products and their approval documents.
- FDA: Drug interactions, what you should know explains how drug-drug, drug-food and drug-condition interactions are described on labels.
- FDA Drug Safety Communications publishes the agency's safety alerts and label changes as they are issued.
- FDA MedWatch is the program for reporting and reviewing adverse events, including suspected interactions.
- openFDA provides public access to FDA labeling and adverse event data.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medicine is and how it is taken.
- NIAAA: Harmful interactions documents which medicines interact with alcohol and how.
- NCCIH: Herb-drug interactions summarises the evidence on interactions between herbal products and medicines.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how this interaction works and where it is documented. It is not medical advice: a prescriber or pharmacist decides what applies to a particular patient and medication.
Frequently Asked Questions
Lisinopril and Spironolactone have a severe interaction and should generally not be taken together without close medical supervision. The combination can cause serious, potentially life-threatening side effects. Contact your doctor immediately if you are currently taking both medications.
Both lisinopril and spironolactone raise potassium levels, and combining them significantly increases the risk of life-threatening hyperkalemia. This can cause cardiac arrhythmias and cardiac arrest. While this combination is sometimes used intentionally in heart failure management, it requires careful monitoring.
Yes. Anytime you are taking multiple medications, supplements, or substances, you should inform your doctor and pharmacist. They can evaluate your specific risk factors (age, kidney function, other medications, medical conditions) and determine whether the Lisinopril and Spironolactone combination is safe for you, or whether adjustments are needed.
Related Resources
Get Drug Safety Alerts
Leave your email for updates on FDA warnings, new drug interactions, and patient safety information. We have not started sending yet, and we will only email when we do.